Outlook Therapeutics (OTLK) Gains from Investment Securities: 2015-2020
Historic Gains from Investment Securities for Outlook Therapeutics (OTLK) over the last 4 years, with Sep 2020 value amounting to $18,115.
- Outlook Therapeutics' Gains from Investment Securities rose 110.51% to $18,115 in Q3 2020 from the same period last year, while for Sep 2020 it was -$783,766, marking a year-over-year increase of 67.85%. This contributed to the annual value of -$38.6 million for FY2024, which is 18657.87% down from last year.
- Latest data reveals that Outlook Therapeutics reported Gains from Investment Securities of $18,115 as of Q3 2020, which was down 99.19% from $2.2 million recorded in Q2 2020.
- In the past 5 years, Outlook Therapeutics' Gains from Investment Securities registered a high of $2.2 million during Q2 2020, and its lowest value of -$3.8 million during Q2 2017.
- In the last 3 years, Outlook Therapeutics' Gains from Investment Securities had a median value of $64,659 in 2018 and averaged $351,296.
- Its Gains from Investment Securities has fluctuated over the past 5 years, first surged by 2,757.59% in 2017, then tumbled by 3,086.81% in 2019.
- Quarterly analysis of 5 years shows Outlook Therapeutics' Gains from Investment Securities stood at $810,083 in 2016, then slumped by 109.73% to -$78,783 in 2017, then crashed by 1,977.00% to -$1.6 million in 2018, then surged by 209.48% to $1.8 million in 2019, then surged by 110.51% to $18,115 in 2020.
- Its last three reported values are $18,115 in Q3 2020, $2.2 million for Q2 2020, and $2.2 million during Q1 2020.